Articles related to Biotec Pharmacon

Biotec Pharmacon targets macrophages with two phase III products

March 4, 2009 - Company: - Tags:

Biotec Pharmacon may have the cure for diabetic foot ulcer with its pharmaceutical formulation of soluble beta glucan (SBG). What is already certain is that Biotec Pharmacon is moving quickly to market with formulations not only for diabetic foot ulcer, but for the treatment of oral mucositis after radio/chemotherapy and immunotherapy of cancer as well.
With Read more »

Newsletter

Subscribe to partneringNEWS
An online journal for executives in the life sciences, partneringNEWS™ is focused on the people behind the deals. Putting a human face to a collaboration agreement gives business development professionals the ability to get behind the headlines.

Sign up today to the free newsletter and never miss any new content.